Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.485 AUD | -6.73% | -4.90% | -14.91% |
May. 28 | Opthea Limited Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD | CI |
May. 28 | Opthea Completes Enrollments in COAST, ShORe Trials | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.91% | 212M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- OPT Stock
- News Opthea Limited
- Opthea Selects Name for Eye Medication Candidate